Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
B01AD10
CAS registry number (Chemical Abstracts Service)
0098530-76-8
Chemical Formula
C2071-H3165-N581-O640-S31
Molecular Weight
47438
Therapeutic Category
Anticoagulant: Thrombin inhibitor
Chemical Name
Blood-coagulation factor XIV (human) (WHO)
Foreign Names
- Drotrecoginum alfa (activatum) (Latin)
- Drotrecogin alfa (aktiviert) (German)
- Drotrécogine alfa (activé) (French)
- Drotrecogina alfa (activada) (Spanish)
Generic Names
- Drotrecogin Alfa (activated) (OS: BAN, USAN)
- Human activated protein C, recombinant (IS)
- LY 203638 (IS: Eli Lilly)
- Protein C human, recombinant (IS)
- Recombinant human activated protein C (IS)
- Rekombinantes humanes aktiviertes Protein C (rhAPC). (IS)
- rhAPC (IS)
Brand Names
- Xigris
Eli Lilly, Canada; Eli Lilly, United Kingdom; Eli Lilly, Netherlands; Eli Lilly, Oman; Eli Lilly, South Africa; Eli Lilly NL B.V., Luxembourg; Lilly, Argentina; Lilly, Austria; Lilly, Australia; Lilly, Belgium; Lilly, Switzerland; Lilly, Chile; Lilly, Czech Republic; Lilly, Germany; Lilly, Denmark; Lilly, Spain; Lilly, Finland; Lilly, France; Lilly, Hong Kong; Lilly, Croatia (Hrvatska); Lilly, Hungary; Lilly, Ireland; Lilly, Israel; Lilly, India; Lilly, Iceland; Lilly, Italy; Lilly, Mexico; Lilly, Malaysia; Lilly, Norway; Lilly, New Zealand; Lilly, Poland; Lilly, Romania; Lilly, Russian Federation; Lilly, Sweden; Lilly, Singapore; Lilly, Slovenia; Lilly, Slovakia; Lilly, Turkey; Lilly, Taiwan; Lilly, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment